Eczema (Atopic Dermatitis) Clinical Trials

A listing of Eczema (Atopic Dermatitis) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 156 clinical trials
featured
Eczema / Atopic Dermatitis

Eczema / Atopic Dermatitis

  • 696 views
  • 23 Nov, 2020
  • 1 location
featured
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

  • 466 views
  • 08 Nov, 2020
  • 1 location
featured
Eczema Research Study - Compensation up to $420

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a board-certified dermatologist at no cost.  

  • 116 views
  • 23 Nov, 2020
  • 1 location
featured
Atopic Dermatitis - Research Study Enrolling

Local physicians are seeking adolescents and adults with moderate to severe atopic dermatitis, also known as eczema. If you have moderate to severe atopic dermatitis , you may be eligible to participate in a clinical study to help evaluate a potential new oral medication that may help.  

  • 64 views
  • 23 Nov, 2020
  • 1 location
featured
Moderate to severe Atopic Dermatitis (Eczema)

Eczema is the most common chronic skin condition in the world. Those with eczema are faced with painful patches that itch and are more at risk for developing secondary infections. Individuals with moderate to sever eczema may qualify for a clinical trial. Contact us today to find out how to …

eczema
atopic dermatitis/eczema
  • 0 views
  • 28 Jan, 2021
  • 1 location
featured
Atopic Dermatitis (Eczema) with Chronic Itching

Does chronic itching from eczema have you ready to shed your skin? Management of chronic itching can be frustrating for both patients and physicians. In any instances, the current therapies available don't provide adequate relief.

  • 0 views
  • 11 Mar, 2021
  • 1 location
featured
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis

This is a 24-week randomized, double blind, placebo controlled, parallel group, dose ranging, Phase 2b study designed to assess the efficacy of different doses and dose regimens of Etokimab compared to placebo in adult subjects with moderate to severe atopic dermatitis (AD). This study will also assess the safety, tolerability, …

  • 53 views
  • 23 Nov, 2020
  • 1 location
featured
We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.

The BLUEPRINT study consists of taking two tablets orally, twice a day, for a period of 4 weeks. This treatment is experimental. You will have 50% chance to receive BLU-5937 and 50% chance to receive the placebo. There will be a total of 5 visits at the clinic and 2 …

adult atopic dermatitis
dermatitis
atopic dermatitis/eczema
eczema
atopic dermatitis
  • 0 views
  • 10 Dec, 2020
  • 25 locations
featured
Atopic Dermatitis In Young Adults

Atopic Dermatitis is a chronic medical condition that has increased over the past two to three decades. It affects between 15-30% of children and 2-10% of adults. Local physicians are currently evaluating a trial medication for Atopic Dermatitis to see if it may help symptoms. Find out more!  

  • 48 views
  • 23 Nov, 2020
  • 1 location
featured
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

eczema
atopic dermatitis
atopic dermatitis/eczema
  • 242 views
  • 14 Dec, 2020
  • 38 locations